Vial - lyophilised powderSubcutaneous (SQ)10 mg

PT 141, also called bremelanotide, is studied for sexual desire rather than simply blood flow. It acts on signalling in the brain and has a defined medical use for a specific patient group in the United States. That does not make every preparation or broader sexual wellness use equivalent.

Shipping Information
Shipping Information

Free Shipping

Decor Outdoor offers free regular shipping on all orders shipped to residential or commercial addresses within the contiguous United States. Orders are delivered Monday through Friday (excluding holidays).

Drop Shipping

We are an online-only luxury furniture and lighting boutique, and do not have a warehouse. Consequently, all orders are drop shipped directly from our manufacturers to your door. If your order includes items from more than one manufacturer, you will receive multiple deliveries. Because we are dependent on the on-hand inventory of our manufacturing partners, some items listed on our site may not actually be available right away. Please call us at 888.784.4644 or via our contact form with any stocking questions and we'll get in touch with the appropriate manufacturer for answers, before you place your order.

Ground Shipping

Small parcel items ship regular ground via delivery services such as FedEx, UPS or DHL. Orders typically take 2-3 business days to process and in-stock items will usually be delivered 3-5 days from the date that they ship (depending on origin and destination). If there is a delay, you will be notified by email. No signature is required for standard ground shipping, so you may want to make arrangements to have packages brought inside soon after delivery, if you are unable to receive it in person.
Storage & Handling

Follow the storage instructions on your product label and the information supplied with your batch. Storage and handling requirements vary by product and presentation.

PT 141 works through signalling pathways in the brain. Its clinical development concerns a specific sexual desire condition, not a general enhancement claim for everyone.

Where It Fits

Specialist sexual health assessment and product specific medical information.

The PHI Perspective

Sexual wellbeing is individual. The value of a defined medical indication lies in knowing who it applies to and who it does not.

How It Works

It acts on melanocortin receptors involved in central signalling. This differs from treatments that primarily act on blood flow.

What the Research Suggests

The clinical evidence concerns bremelanotide for a defined patient group and licensed preparation. Broader sexual enhancement claims or equivalence of this vial cannot be assumed.

Evidence level: Human trials and a defined medical indication for licensed bremelanotide. Not an approval of this PHI vial.

Storage & Handling

Store lyophilised vial at 2-8 C, protected from light.

Active compound: PT-141 / Bremelanotide

Mechanism of Action

Agonist at melanocortin receptors, principally MC4R, in the central nervous system. Acts on hypothalamic pathways governing sexual desire and arousal, upstream of the vascular mechanisms targeted by PDE5 inhibitors. The effect is on desire and central arousal rather than on peripheral blood flow.

Clinical Evidence Base

Two Phase III randomised placebo-controlled trials in premenopausal women with HSDD demonstrated statistically significant improvements in desire and reduction in distress, supporting FDA approval. Earlier Phase II work examined erectile dysfunction. Evidence in men and in postmenopausal women is limited; use in those groups is off-label.

Safety & Precautions

The most common adverse effects in trials were nausea, affecting a substantial proportion of participants, flushing and headache. Transient increases in blood pressure with reductions in heart rate occur and are clinically relevant: it is contraindicated in uncontrolled hypertension and known cardiovascular disease. Focal hyperpigmentation may occur with repeated use, more commonly in patients with darker skin. Contraindicated in pregnancy. There is a limit on dosing frequency in the licensed product that should be observed.

Contraindications

Uncontrolled hypertension; known cardiovascular disease; pregnancy and breastfeeding; known hypersensitivity.

Literature & References

Kingsberg SA et al. Obstet Gynecol, 2019 - bremelanotide for HSDD, the RECONNECT trials. | Clayton AH et al. Womens Health (Lond), 2016 - bremelanotide Phase IIb in premenopausal women. | Diamond LE et al. Int J Impot Res, 2004 - intranasal bremelanotide in erectile dysfunction. | US FDA prescribing information, Vyleesi (bremelanotide) injection, 2019.

Select the fields to be shown. Others will be hidden. Drag and drop to rearrange the order.
  • Image
  • SKU
  • Rating
  • Price
  • Stock
  • Availability
  • Add to cart
  • Description
  • Content
  • Weight
  • Dimensions
  • Additional information
Click outside to hide the comparison bar
Compare